LifeMD
LFMD
128 hedge funds and large institutions have $326M invested in LifeMD in 2025 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 51 increasing their positions, 24 reducing their positions, and 18 closing their positions.
264% more capital invested
Capital invested by funds: $89.7M → $326M (+$236M)
139% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 18
113% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 24
83% more call options, than puts
Call options by funds: $17.3M | Put options by funds: $9.44M
24% more funds holding
Funds holding: 103 → 128 (+25)
15.71% more ownership
Funds ownership: 36.98% → 52.69% (+16%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$8.33M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$8.12M |
| 3 |
Morgan Stanley
New York
|
+$8M |
| 4 |
D.E. Shaw & Co
New York
|
+$6.08M |
| 5 |
Renaissance Technologies
New York
|
+$5.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.58M |
| 2 |
RA
Royce & Associates
New York
|
-$3.63M |
| 3 |
Millennium Management
New York
|
-$3.48M |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
-$1.78M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.72M |
LFMD Hedge Fund Activity: Q2 2025 in Review
128 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q2 2025, worth a combined $326M — up 264% from $89.7M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new LFMD positions and 18 closed out — a net gain of 25 holders — while 51 added to existing stakes and 24 trimmed.
The largest buyer was Nuveen, adding an estimated $8.33M. The largest seller was Citadel Advisors, exiting entirely with an estimated $4.58M sold.
- 128 institutional investors held LifeMD (LFMD) as of Q2 2025, up from 103 in Q1 2025.
- Funds reported $326M of LifeMD stock for Q2 2025, up 264% quarter-over-quarter.
- 43 funds opened new LifeMD positions in Q2 2025 and 18 closed out, a net change of +25 holders.
- The largest LifeMD buyer in Q2 2025 was Nuveen, an estimated $8.33M added.
- The largest LifeMD seller in Q2 2025 was Citadel Advisors, an estimated $4.58M sold.
Based on aggregated 13F filings for Q2 2025.